Parenteral excipients are substances used in the formulation of injectable drugs. They are an important component of parenteral products as they help to stabilize, solubilize, and enhance the delivery of active pharmaceutical ingredients (APIs) to the patient.
Pharma Excipients
Parenteral Excipients
High Quality from Source to Final Product – Refined Olive Oil IV
ADMs Refined Olive Oil IV is a highly purified olive oil fully compliant with the European Pharmacopoeia (1456) and United States Pharmacopeia/National Formulary (USP/NF) monographs and general notices intended for use in the manufacturing of pharmaceutical products.
Unmatched Quality for Use as…
Read More...
Read More...
Hypericin emulsomes combined with hollow microneedles as a non-invasive photodynamic platform for…
Rheumatoid arthritis (RA) is a joint-destructive autoimmune disease that severely affects joint function. Despite the variability of treatment protocols, all of them are associated with severe side effects that compromise patient compliance. The main aim of the current study is to prepare localized…
Read More...
Read More...
PhytoSquene® – Your plant-derived squalene for parenteral applications
PRESERVING BIODIVERSITY AND ENSURING SAFETY WITH NON-ANIMAL-DERIVED SQUALENE
PhytoSquene® is our non-animal-derived squalene that can be used in vaccines and other pharmaceutical applications. This alternative to animal-derived squalene has many benefits. PhytoSquene® reduces the need to…
Read More...
Read More...
High purity excipients for parenteral drug delivery
Parenteral formulation frequently faces limitations associated with drug stability and poor solubility. Drug compatibility and the minimum concentration of drug required to produce the targeted pharmacological effect are key to excipient selection.
Your partner for parenteral formulations:…
Read More...
Read More...
Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection
A dry powder inhaled liposomal azithromycin formulation was developed for the treatment of chronic respiratory diseases such as cystic fibrosis and bronchiectasis. Key properties including liposome size, charge and encapsulation efficiency powder size, shape, glass transition temperature (Tg), water…
Read More...
Read More...
Mineral Salts Low in Endotoxins for parenteral Medicines
Endotoxins are lipopolysaccharides (LPS) which are outer membrane components of gram-negative bacteria. By decomposing, these bacteria release lipopolysaccharides, which are toxic.
Parenteral medicines such as solutions for dialysis, hemofiltration and osmotherapy constitute a marked quality…
Read More...
Read More...
Microneedle-Mediated Transdermal Delivery of Genetic Materials, Stem Cells, and Secretome: An Update…
Abstract
Medical practitioners commonly use oral and parenteral dosage forms to administer drugs to patients. However, these forms have certain drawbacks, particularly concerning patients’ comfort and compliance. Transdermal drug delivery presents a promising solution to address these issues.…
Read More...
Read More...
Viatel™ Bioresorbable Polymers – by Ashland
Ashland is a premier global specialty chemicals company serving customers in a wide range of consumer and industrial markets. With the Viatel™ platform, Ashland offers five families of bioresorbable polymers for parenteral controlled release drug delivery systems and medical devices.
viatel™…
Read More...
Read More...
In vivo pharmacodynamics of lactoferrin-coupled lipid nanocarriers for lung carcinoma: intravenous…
Lung carcinoma characterized by high mortality rate and poor prognosis; the efficacy of drug delivery should improve drug exposure at the targeted site. This study aims at evaluating lactoferrin role as targeting ligand besides the administration route impact on tissue deposition and organ…
Read More...
Read More...
Development of the Composition and Technology for Obtaining a Model of an Injection Form of an…
The indolocarbazole derivative LCS-1269 has a multitarget mechanism of action on tumors and blocks vasculogenic mimicry. The hydrophobic character of LCS-1269 hampers the development of an injectable dosage form (IDF), the need for which was determined in series of in vitro and in vivo…
Read More...
Read More...